Fundz

Boston Medical Sciences has raised ¥5.55B in a Series B funding round to accelerate R&D and clinical trials for AI-driven solutions in colorectal cancer detection.

PRIVATENov 16, 2026

Amount Raised

¥5.55 Billion

Round Type

Series B

TokyoBiotechnologyHealth CareArtificial IntelligenceMedicalMedical DeviceMachine Learning

Investors

Beyond Next Ventures Inc.Global Brain CorporationJapan Growth Capital Investment Corporation

Description

Boston Medical Sciences, a Tokyo-based medical technology startup, has raised 5.55 billion yen in a Series B funding round. The funding will be used to support regulatory efforts in Japan and the United States, and to expand overseas operations, particularly in the U.S. market. Investors include Japan Growth Capital Investment Corporation, Global Brain Corporation, and Beyond Next Ventures Inc

Quick answer

Boston Medical Sciences raised ¥5.55 Billion in a Series B round, dated November 13, 2026. Investors: Beyond Next Ventures Inc., Global Brain Corporation and Japan Growth Capital Investment Corporation. Boston Medical Sciences is based in Tokyo, Japan.

How much did Boston Medical Sciences raise?
Boston Medical Sciences raised ¥5.55 Billion in a Series B round on November 13, 2026.
Who invested in Boston Medical Sciences?
Beyond Next Ventures Inc., Global Brain Corporation and Japan Growth Capital Investment Corporation are named as investors in this round.
What does Boston Medical Sciences do?
Boston Medical Sciences is a Tokyo-based medical technology startup founded in 2023 by physicians with experience at Harvard Medical School and Massachusetts General Hospital.
Where is Boston Medical Sciences based and how big is it?
Boston Medical Sciences is based in Tokyo, Japan.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Boston Medical Sciences that raised within 45 days of this round, from Fundz verified event records.

  • Laza Medical raised $160M (Series B) on November 4, 2026.
  • Scarlet raised $50M (Series B) on October 12, 2026.
  • AIBORN Ltd raised an undisclosed amount on October 5, 2026.
  • Kardi Ai raised $5.9M (Series A) on November 11, 2026.
  • Alterra Labs raised $13M (Seed) on November 10, 2026.
  • Impress raised $45M (Debt Financing) on October 27, 2026.

Who to call at Boston Medical Sciences, and when

A new round usually means Boston Medical Sciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Boston Medical Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Boston Medical Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Boston Medical Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Boston Medical Sciences

Location

Tokyo, Japan

About

Boston Medical Sciences is a Tokyo-based medical technology startup founded in 2023 by physicians with experience at Harvard Medical School and Massachusetts General Hospital. The company focuses on developing AI-driven medical solutions for the early detection and examination of colorectal cancer. Their proprietary technology includes Laxative-Free Virtual Endoscopy, employing AI-powered image analysis. They aim to prevent deaths from colorectal cancer through innovative research and development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Boston Medical Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Boston Medical Sciences's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Boston Medical Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.